newsfilter
← Latest News
GlobeNewswire·

InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium

JENA, Germany, March 31, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will